Clin2
NCT06569667Possibly a fitRecruiting

AI and peer coaching for Black and Latinx adults using opioids

Opioid Use Disorder

Treatments studied

Part of Mental health clinical trials.

This study tests whether AI and peer coaching can help Black and Latinx people who use opioids start buprenorphine treatment and reduce racial disparities. It's designed for people in New York City who are interested in starting this medication.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
292 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • 18 years old or older
  • Speak English or Spanish
  • Used non-prescription opioids in the last 30 days
  • Identify as Black and/or Latinx
  • Live in New York City for at least the next 12 months
  • Have a mobile phone with a data plan

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06573476Recruiting
Smartphone app and peer coach for opioid treatment

This study tests whether a smartphone app and support from a peer recovery coach can help Black and Latinx individuals with opioid use disorder start buprenorphine treatment. The goal is to reduce overdose deaths and address racial gaps in care.

New York, New York
NCT05033028Recruiting· Phase 3
Using a smartphone to support opioid addiction recovery

This Phase 3 study tests whether using smartphones can help people with opioid-use disorder stick with treatment and recover more successfully. It focuses on people starting or already in treatment using methadone or buprenorphine, with support delivered through the study app or messages.

Piscataway, New Jersey
NCT06341608Not yet recruiting
Telehealth for opioid use disorder treatment

This study tests whether a tailored telehealth program can help people with opioid use disorder get better access to treatment. It is designed for patients who are already receiving or starting treatment with buprenorphine at Prevention Point Philadelphia.

Philadelphia, Pennsylvania
NCT07362082Not yet recruiting
Telehealth treatment for opioid use disorder

This study tests whether treatment for opioid use disorder can be done effectively through telehealth (video calls and texts). It is designed for people who are not currently on medication for opioid addiction and want to start treatment from home.

New Haven, Connecticut
NCT07176351Not yet recruiting· Phase 4
Mobile clinic study of extended-release buprenorphine for opioid use disorder

This trial tests a long-acting, once-monthly injection of buprenorphine (BRIXADI) given from a mobile pharmacy clinic. It aims to see if this approach is acceptable and practical for people with opioid use disorder, making treatment more accessible.

New Haven, Connecticut
NCT05138614Recruiting
Help for people with opioid use disorder and mental health needs

This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.

Holyoke, Massachusetts

Hear when a new Opioid Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.